enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Anti-asthmatic agent - Wikipedia

   en.wikipedia.org/wiki/Anti-asthmatic_agent

   Mast cell stabilizers are given as prophylactic treatment to prevent exacerbation of asthmatic symptoms. [22] For asthma maintenance therapy, mast cell stabilizers are taken by inhalation. [2] Common adverse effects of Mast cell stabilizers include mouth dryness, cough, throat irritation, nasal congestion and bronchospasm. [23]

3. Telltale Signs You Need to See a Doctor for Your Cough - AOL

   www.aol.com/telltale-signs-see-doctor-cough...

   Asthma. Chronic obstructive pulmonary disease (COPD) ... Home remedies for a cough. ... Take an OTC cough medication like guaifenesin or an antitussive medication like dextromethorphan.

4. Doctors Say This Is How You Can Loosen and Clear Mucus From ...

   www.aol.com/lifestyle/doctors-loosen-clear-mucus...

   Coughing is a physiologic way to rid one of some of the congestion, says Amesh A. Adalja, M.D., senior scholar at the Johns Hopkins Center for Health Security. Controlled cough is a mucus-clearing ...

5. Benzonatate - Wikipedia

   en.wikipedia.org/wiki/Benzonatate

   Benzonatate is a prescription non-opioid alternative for the symptomatic relief of cough. [7] [9] It has been found to improve cough associated with a variety of respiratory conditions including asthma, bronchitis, pneumonia, tuberculosis, pneumothorax, opioid-resistant cough in lung cancer, and emphysema. [7] [5] [18]

6. Formoterol - Wikipedia

   en.wikipedia.org/wiki/Formoterol

   Formoterol, also known as eformoterol, is a long-acting β 2 agonist (LABA) used as a bronchodilator in the management of asthma and chronic obstructive pulmonary disease (COPD). Formoterol has an extended duration of action (up to 12 h) compared to short-acting β 2 agonists such as salbutamol (albuterol), which are effective for 4 h to 6 h.

7. FDA approves medication used to treat asthma for use in ...

   www.aol.com/fda-approves-medication-used-treat...

   Xolair, which is developed and co-promoted by Genentech and Novartis in the US, was originally approved in 2003 for the treatment of moderate to severe persistent allergic asthma in certain people.